Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

PURPOSE: A novel transdermal formulation of granisetron (the granisetron transdermal delivery system (GTDS)) has been developed to deliver granisetron continuously over 7 days. This double-blind, phase III, non-inferiority study compared the efficacy and tolerability of the GTDS to daily oral granis...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Boccia, Ralph V., Gordan, Lucio N., Clark, Gemma, Howell, Julian D., Grunberg, Steven M.
Formato: Artigo
Idioma:Inglês
Publicado: Springer-Verlag 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166600/
https://ncbi.nlm.nih.gov/pubmed/20835873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-010-0990-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares